Skip to main content
. 2020 Apr 6;10(12):5181–5194. doi: 10.7150/thno.44693

Table 1.

Patients demographics and clinical characteristics

Characteristics No. (%)
Age at baseline, years
Median 63
range 34-83
Sex
Male 15 (37.5)
Female 25 (62.5)
M stage at diagnosis
M0 3 (7.5)
M1a 6 (15)
M1b 31 (77.5)
EGFR mutation
19del 19 (47.5)
L858R 16 (40)
Others 5 (12.5)
EGFR-TKI received
Gefitinib 2 (5)
Erlotinib 9 (22.5)
Afatinib 29 (72.5)